APA

Manso L., Moreno F., Márquez R., Castelo B., Arcediano A., Arroyo M., Ballesteros A. I., Calvo I., Echarri M. J., Enrech S., Gómez A., González Del Val R., López-Miranda E., Martín-Angulo M., Martínez-Jañez N., Olier C. & Zamora P. (20150424). Use of bevacizumab as a first-line treatment for metastatic breast cancer. : Current oncology (Toronto, Ont.).

Chicago

Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros A I, Calvo I, Echarri M J, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C and Zamora P. 20150424. Use of bevacizumab as a first-line treatment for metastatic breast cancer. : Current oncology (Toronto, Ont.).

Harvard

Manso L., Moreno F., Márquez R., Castelo B., Arcediano A., Arroyo M., Ballesteros A. I., Calvo I., Echarri M. J., Enrech S., Gómez A., González Del Val R., López-Miranda E., Martín-Angulo M., Martínez-Jañez N., Olier C. and Zamora P. (20150424). Use of bevacizumab as a first-line treatment for metastatic breast cancer. : Current oncology (Toronto, Ont.).

MLA

Manso L, Moreno F, Márquez R, Castelo B, Arcediano A, Arroyo M, Ballesteros A I, Calvo I, Echarri M J, Enrech S, Gómez A, González Del Val R, López-Miranda E, Martín-Angulo M, Martínez-Jañez N, Olier C and Zamora P. Use of bevacizumab as a first-line treatment for metastatic breast cancer. : Current oncology (Toronto, Ont.). 20150424.